Upgrade to SI Premium - Free Trial

Evolus (EOLS) PT Raised to $14 at Barclays

November 5, 2019 4:46 AM
Barclays analyst Balaji Prasad raised the price target on Evolus (NASDAQ: EOLS) to $14.00 (from $13.00) while maintaining a Underweight rating.

Categories

Analyst PT Change

Next Articles